# Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

> **NCT06877416** · — · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 700 (estimated)

## Conditions studied

- Antibody-drug Conjugates
- HER2-low Breast Cancer
- Breast Neoplasms

## Interventions

- **OTHER:** Non-intervention research

## Key facts

- **NCT ID:** NCT06877416
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06877416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06877416, "Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06877416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*